Rivaara Labs

Rivaara Labs, founded in 2019, is a biotechnology and healthcare startup focused on advancing precision diagnostics with timely, actionable solutions for improved healthcare outcomes. The company's offerings include molecular diagnostics services, clinical testing solutions, and innovative Point of Care (POC) solutions. With a strategic emphasis on building a wide network of specialized Molecular Diagnostics labs and a national reference lab, Rivaara Labs addresses the critical need for prompt, actionable information that transcends the limitations of current diagnostic and monitoring practices. The company's open, dynamic, and collaborative culture empowers teams to drive innovation in the healthcare space. In its latest funding round on 07 November 2022, Rivaara Labs secured a substantial INR600.00M investment from Kotak Investment Advisors, BHARAT V. DAFTARY, and Amicus Capital, showcasing confidence from prominent investors in the startup's vision. Rivaara Labs' commitment to bridging the gap in precision diagnostics positions it as a promising player in the biotechnology and healthcare industries, offering compelling opportunities for potential stakeholders and investors.